Table 2.

Estimated Causal Treatment Effects on MOW Recipients.

30 Day Outcome	${\overline{n}}_G$	$\overline{\mathbf{D}}(1)$	$\overline{\mathbf{D}}(0)$	${\widehat{\tau }}_{ATT}$	95% CI
Mortality	1859.67	0.023(0.001)	0.015(0.004)	0.008	(−0.067, 0.083)
30 Day Outcome	${\overline{n}}_S$	$\overline{\mathbf{H}}(1)$	$\overline{\mathbf{H}}(0)$	${\widehat{\tau }}_{SATT}$	95% CI
Inpatient Acute	1808.46	0.085(0.002)	0.075(0.010)	0.010	(−0.174, 0.194)
Emergency Care	1808.46	0.073(0.002)	0.088(0.012)	−0.013	(−0.236, 0.209)
Nursing Home	1808.46	0.078(0.003)	0.075(0.015)	0.003	(−0.268, 0.274)

${\overline{n}}_G$ is the average sample size of MOW individuals linked and matched to a control individual across M = 100 imputations. ${\overline{n}}_S$ is the average number of linked and matched MOW individuals who are observed and predicted to be alive irrespective of their treatment, across M × Q = 10,000 imputations. $\overline{\mathbf{D}}(1)$ and $\overline{\mathbf{D}}(0)$ represent the mortality rates for linked and matched MOW individuals if they received MOW or not, respectively. $\overline{\mathbf{H}}(1)$ and $\overline{\mathbf{H}}(0)$ are the estimated healthcare utilization rates for linked and matched individuals who are alive for 30 days irrespective of whether they received MOW or not, respectively. ${\widehat{\tau }}_{ATT}$ is the estimated average treatment effect on the treated and ${\widehat{\tau }}_{SATT}$ is the survivor average treatment effect on the treated